At the cellular level, MDSCs derange immune checkpoint pathways and several studies have reported that high PD-L1 expression on blood MDSCs of cancer patients correlates with disease stage, acting as negative regulators of T and NK cell functions in TME [78]. This evidence concerns the gene CD274 and cancer.